AbbVie's Rinvoq label portends safety warnings for future JAKs—including Gilead's

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 20, 2019 at 9:52 AM.

  1. #1 cafead, Aug 20, 2019 at 9:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,013
    Likes Received:
    3
    via Drugs from the burgeoning JAK group have so far run into their fair share of safety liabilities, and if the label for new AbbVie med Rinvoq is any indication, the FDA now believes those issues are class-wide.

    article source
     
    Quote

Reply to Thread